StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the stock.
Ayala Pharmaceuticals Stock Performance
Shares of ADXS opened at $0.02 on Wednesday. The firm has a market cap of $852,660.00, a P/E ratio of 0.00 and a beta of 1.56. Ayala Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $1.49. The stock’s 50 day moving average is $0.15 and its two-hundred day moving average is $0.44.
Ayala Pharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Ayala Pharmaceuticals
- About the Markup Calculator
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Options Trading – Understanding Strike Price
- MarketBeat Week in Review – 8/12 – 8/16
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.